Abstract:Introduction: Post-stroke depression (PSD) is a common mental health problem after cerebrovascular accidents. There are several treatments that have been shown to be effective in treating post-stroke depression. However, it is not clear which treatment is more effective. Methods: In this meta-analysis, an appropriate search strategy was used to search eligible randomized controlled trials (RCTs) on different treatments to treat patients with Post-stroke depression published up to December 2021 from the CNKI, PubMed, and Cochrane Library. We assessed the mean difference or odds ratio between each treatment and placebo and summarized them as the average and 95% confidence interval (CI) by conducting Bayesian network meta-analyses. Results: By constructing a Bayesian network meta-analysis, we found that acupuncture combined with fluoxetine (vs placebo MD, −8.9; 95% CI, [−15, −2.9]) or paroxetine (vs placebo MD,—8.5; 95% CI, [−15, −2.5]) was the most effective for change in Hamilton depression scale (HAMD) at the end of the 4th week. For change in Hamilton depression scale at the end of the 8th week, rTMS combined with paroxetine (vs placebo MD, −13; 95% CI, [−17, −7.9]) had the greatest amount of change. The efficacy of medication combined with adjuvant therapy was also superior for the percentage of patients with Hamilton depression scale change over 50%. Discussion: The combination of antidepressants with adjuvant therapy may enhance the efficacy of antidepressants and achieve better results than antidepressant monotherapy in both Hamilton depression scale changes at the end of week 4 or 8 and 50% Hamilton depression scale improvement rate. Acupuncture combined with fluoxetine treatment was more effective in the treatment of post-stroke depression at week 4, while rTMS combined with paroxetine was more effective at week 8. Further research is needed to determine whether acupuncture combined with fluoxetine is better than rTMS combined with paroxetine for post-stroke depression at week 8.

Comparative Study of Efficacy and Safety of Mirtozapine and Doxepine in Treatment of Patients with Post-stroke Depression

A comparative study of treatment of depression:Mirtazapine vs.fluoxepine

Consensus of mirtazapine in treatment of depression

Randomized,multicenter,double blind comparative trial of reboxetine in the treatment of depression with or without anxiety

A Study on Mirtazapine and Citalopram in the Treatment of Depression

Control study of mirtazapine and fluoxetine in therapy of depression

The Efficacy and Safety of Mirtazapine and Fluoxetine for Depression:A Meta-analysis

Treatments to post-stroke depression, which is more effective to HAMD improvement? A network meta-analysis

The Efficacy of Therapies for Post-Stroke Depression in Aging: an Umbrella Review.

The infection of clinic psychological care of partients with post-stroke depression

Efficacy and safety of fluoxetine for the treatment of post-stroke depression:a meta-analysis

Efficacy and safety of agomelatine versus SSRIs/SNRIs for post-stroke depression: a systematic review and meta-analysis of randomized controlled trials

Clinical Research on Jiaweiwendan Decoction Combined with Deanxit in Treating Post Stroke Depression

Comparative Analysis of the Effects of Escitalopram, Pramipexole, and Transcranial Magnetic Stimulation on Depression in Patients With Parkinson Disease: An Open-Label Randomized Controlled Trial

A study of antidepressant augmentation with mirtazapine in outpatients with major depression

A Preliminary Study of Different Treatment Strategies for Anxious Depression.

Clinical Observation on Auricular Points Plaster Therapy Combined with Chaihu Jieyu Decoction Treatment of Post Stroke Depression

Efficacy of escitalopram for poststroke depression: a systematic review and meta-analysis

Mirtazapine and Fluoxetine in the Treatment of Cardiovascular Neurosis with Depression

Clinical Research of the Elderly Patients with Post-Stroke Depression

Effect of the combination of cognitive behavioral therapy and oral paroxetine hydrochloride in patients with post-stroke depression